NBTX
Nanobiotix (NBTX)
$32
About Nanobiotix (NBTX)
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Details
Daily high
$22.58
Daily low
$22.17
Price at open
$22.35
52 Week High
$30.35
52 Week Low
$2.82
Market cap
1.1B
Dividend yield
0.00%
Volume
15,758
Avg. volume
46,526
P/E ratio
-28.04
Nanobiotix News
Details
Daily high
$22.58
Daily low
$22.17
Price at open
$22.35
52 Week High
$30.35
52 Week Low
$2.82
Market cap
1.1B
Dividend yield
0.00%
Volume
15,758
Avg. volume
46,526
P/E ratio
-28.04